المؤلفون: Gang, Anne O., Pedersen, Michael, d'Amore, Francesco, Pedersen, Lars M., Jensen, Bo A., Jensen, P., Moller, M. B., Mourits-Andersen, Hans Torben, Pedersen, R. S., Klausen, T. W., De, N. Brown P.

المصدر: Gang , A O , Pedersen , M , d'Amore , F , Pedersen , L M , Jensen , B A , Jensen , P , Moller , M B , Mourits-Andersen , H T , Pedersen , R S , Klausen , T W & De , N B P 2015 , ' A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification : Population-based analysis from the Danish Lymphoma Registry ' , Leukemia and Lymphoma , vol. 56 , no. 9 , pp. 2556-2562 ....

مصطلحات موضوعية: age aged albumin blood level article autologous stem cell transplantation cancer combination chemotherapy cancer mortality *cancer registry cancer survival controlled study female follow up hemoglobin blood level human *International Prognostic Index lactate dehydrogenase blood level *large cell lymphoma/dt [Drug Therapy] lymphocyte count major clinical study male priority journal albumin/ec [Endogenous Compound] cyclophosphamide/cb [Drug Combination] cyclophosphamide/dt [Drug Therapy] doxorubicin/cb [Drug Combination] doxorubicin/dt [Drug Therapy] hemoglobin/ec [Endogenous Compound] immunoglobulin G/ec [Endogenous Compound] lactate dehydrogenase/ec [Endogenous Compound] prednisone/cb [Drug Combination] prednisone/dt [Drug Therapy] rituximab/cb [Drug Combination] rituximab/dt [Drug Therapy] vincristine/cb [Drug Combination] vincristine/dt [Drug Therapy], Diffuse large B-cell lymphoma, prognostic index, rituximab, treatment, Multivariate Analysis, Prognosis, Age Factors, Humans, Middle Aged, Male, Young Adult, Registries/statistics & numerical data, Aged, 80 and over, Adult, Female, Kaplan-Meier Estimate, Proportional Hazards Models, Combined Modality Therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Lymphoma, Large B-Cell, Diffuse/diagnosis, Stem Cell Transplantation/methods, Adolescent, Denmark, Outcome Assessment, Health Care/methods, Cohort Studies

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/ad5ac118-7170-460b-abdc-27bdf84710e2Test

الإتاحة: https://doi.org/10.3109/10428194.2015.1010078Test
https://portal.findresearcher.sdu.dk/da/publications/ad5ac118-7170-460b-abdc-27bdf84710e2Test

المؤلفون: Michael Pedersen, Michael Boe Møller, Hans Torben Mourits-Andersen, Anne O. Gang, Peter N. Brown, Bo Amdi Jensen, Francesco d'Amore, Paw Jensen, Tobias Wirenfeldt Klausen, Lars Møller Pedersen, Robert Smith Pedersen

المصدر: Gang, A O, Pedersen, M, d'Amore, F, Pedersen, L M, Jensen, B A, Jensen, P, Møller, M B, Mourits-Andersen, H T, Pedersen, R S, Klausen, T W & de N Brown, P 2015, ' A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification : population-based analysis from the Danish Lymphoma Registry ', Leukemia and Lymphoma, vol. 56, no. 9, pp. 2556-2562 . https://doi.org/10.3109/10428194.2015.1010078Test
Gang, A O, Pedersen, M, d'Amore, F, Pedersen, L M, Jensen, B A, Jensen, P, Moller, M B, Mourits-Andersen, H T, Pedersen, R S, Klausen, T W & De, N B P 2015, ' A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification : Population-based analysis from the Danish Lymphoma Registry ', Leukemia and Lymphoma, vol. 56, no. 9, pp. 2556-2562 . https://doi.org/10.3109/10428194.2015.1010078Test

مصطلحات موضوعية: Male, Oncology, Cancer Research, Pathology, Denmark, Kaplan-Meier Estimate, Cohort Studies, rituximab, International Prognostic Index, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Outcome Assessment, Health Care, Registries, Stage (cooking), Aged, 80 and over, Lymphoma, Large B-Cell, Diffuse/diagnosis, education.field_of_study, treatment, Age Factors, Registries/statistics & numerical data, Outcome Assessment, Health Care/methods, Diffuse large B-cell lymphoma, Hematology, Middle Aged, Prognosis, Combined Modality Therapy, Cohort, Female, Rituximab, Lymphoma, Large B-Cell, Diffuse, medicine.drug, Adult, medicine.medical_specialty, Stem Cell Transplantation/methods, Adolescent, Population, age aged albumin blood level article autologous stem cell transplantation cancer combination chemotherapy cancer mortality *cancer registry cancer survival controlled study female follow up hemoglobin blood level human *International Prognostic Index lactate dehydrogenase blood level *large cell lymphoma/dt [Drug Therapy] lymphocyte count major clinical study male priority journal albumin/ec [Endogenous Compound] cyclophosphamide/cb [Drug Combination] cyclophosphamide/dt [Drug Therapy] doxorubicin/cb [Drug Combination] doxorubicin/dt [Drug Therapy] hemoglobin/ec [Endogenous Compound] immunoglobulin G/ec [Endogenous Compound] lactate dehydrogenase/ec [Endogenous Compound] prednisone/cb [Drug Combination] prednisone/dt [Drug Therapy] rituximab/cb [Drug Combination] rituximab/dt [Drug Therapy] vincristine/cb [Drug Combination] vincristine/dt [Drug Therapy], Young Adult, Internal medicine, medicine, Humans, education, Proportional Hazards Models, Aged, Performance status, business.industry, prognostic index, medicine.disease, Lymphoma, Multivariate Analysis, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, business, Stem Cell Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53fe296ae55ebfc74e41b3dfbcd76e4Test
https://pure.au.dk/portal/da/publications/a-clinically-based-prognostic-index-for-diffuse-large-bcell-lymphoma-with-a-cutoff-at-70-years-of-age-significantly-improves-prognostic-stratificationTest(81189750-9f11-47ed-b80d-ff3d5d508d6d).html

مصطلحات الفهرس: aged, article, bullous pemphigoid/dt [Drug Therapy], cancer combination chemotherapy, child, comorbidity, controlled study, Cytomegalovirus, cytomegalovirus infection/di [Diagnosis], cytomegalovirus infection/dt [Drug Therapy], cytomegalovirus infection/th [Therapy], diagnostic test accuracy study, diffuse large B cell lymphoma/dt [Drug Therapy], female, human, immunocompromised patient, immunosuppressive treatment, incidental finding, infant, liver failure/dt [Drug Therapy], liver failure/su [Surgery], liver transplantation, lupus erythematosus nephritis/dt [Drug Therapy], major clinical study, male, medical record review, middle aged, mouth ulcer, mucus, multiplex polymerase chain reaction, newborn, outcome assessment, palliative therapy, pathologist, pemphigus vulgaris/dt [Drug Therapy], predictive value, preschool child, priority journal, retrospective study, rheumatoid arthritis/dt [Drug Therapy], school child, prednisolone/dt [Drug Therapy], valganciclovir/dt [Drug Therapy], polymerase chain reaction system, mucosal swab, 2012-15 AusDiagnostics Easy-Plex 12-well assay, 2015-16 AusDiagnostics High-Plex Herpes, Enterovirus and Adenovirus 16-well assay, antiviral therapy, skin biopsy, skin injury, smear, statistically significant result, systemic disease, T cell lymphoma/dt [Drug Therapy], very elderly, virus detection, young adult, azathioprine/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], cyclophosphamide plus doxorubicin plus etoposide plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], ganciclovir/dt [Drug Therapy], ganciclovir/iv [Intravenous Drug Administration], methotrexate/dt [Drug Therapy], adolescent, adult, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29260Test
Pathology
LibKey Link

مصطلحات الفهرس: Myc protein, letter, drug dose intensification, fluorescence in situ hybridization, health care quality, human, International Prognostic Index, large cell lymphoma/dt [Drug Therapy], overall survival, patient selection, priority journal, progression free survival, stem cell transplantation, cyclophosphamide plus doxorubicin plus etoposide plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35741Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: Myc protein, letter, drug dose intensification, fluorescence in situ hybridization, health care quality, human, International Prognostic Index, large cell lymphoma/dt [Drug Therapy], overall survival, patient selection, priority journal, progression free survival, stem cell transplantation, cyclophosphamide plus doxorubicin plus etoposide plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35741Test
LibKey Link

مصطلحات الفهرس: observational study, oncological parameters, overall response rate, overall survival, primary central nervous system lymphoma/dt [Drug Therapy], primary central nervous system lymphoma/rt [Radiotherapy], priority journal, progression free survival, retrospective study, salvage therapy, survival analysis, survival rate, treatment outcome, treatment refusal, treatment response, whole brain radiotherapy, corticosteroid, cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/to [Drug Toxicity], cytarabine/pv [Special Situation for Pharmacovigilance], cytarabine/tm [Unexpected Outcome of Drug Treatment], methotrexate/ae [Adverse Drug Reaction], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], methotrexate/to [Drug Toxicity], methotrexate/tl [Intrathecal Drug Administration], methotrexate/pv [Special Situation for Pharmacovigilance], methotrexate/tm [Unexpected Outcome of Drug Treatment], procarbazine/ae [Adverse Drug Reaction], procarbazine/cb [Drug Combination], procarbazine/dt [Drug Therapy], procarbazine/to [Drug Toxicity], procarbazine/pv [Special Situation for Pharmacovigilance], procarbazine/tm [Unexpected Outcome of Drug Treatment], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], rituximab/to [Drug Toxicity], rituximab/pv [Special Situation for Pharmacovigilance], rituximab/tm [Unexpected Outcome of Drug Treatment], vincristine/ae [Adverse Drug Reaction], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], vincristine/to [Drug Toxicity], vincristine/pv [Special Situation for Pharmacovigilance], vincristine/tm [Unexpected Outcome of Drug Treatment], complete response rate, drug fatality/si [Side Effect], adult, age, aged, article, cancer combination chemotherapy, cancer patient, cancer prognosis, cancer radiotherapy, cancer regression, cancer survival, clinical article, clinical outcome, cohort analysis, consolidation chemotherapy, controlled study, drug dose reduction, drug megadose, female, human, immunocompetence, male, median survival time, multiple cycle treatment, neurotoxicity/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27443Test
Leukemia and Lymphoma
Click here for full text options
LibKey Link

مصطلحات الفهرس: observational study, oncological parameters, overall response rate, overall survival, primary central nervous system lymphoma/dt [Drug Therapy], primary central nervous system lymphoma/rt [Radiotherapy], priority journal, progression free survival, retrospective study, salvage therapy, survival analysis, survival rate, treatment outcome, treatment refusal, treatment response, whole brain radiotherapy, corticosteroid, cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/to [Drug Toxicity], cytarabine/pv [Special Situation for Pharmacovigilance], cytarabine/tm [Unexpected Outcome of Drug Treatment], methotrexate/ae [Adverse Drug Reaction], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], methotrexate/to [Drug Toxicity], methotrexate/tl [Intrathecal Drug Administration], methotrexate/pv [Special Situation for Pharmacovigilance], methotrexate/tm [Unexpected Outcome of Drug Treatment], procarbazine/ae [Adverse Drug Reaction], procarbazine/cb [Drug Combination], procarbazine/dt [Drug Therapy], procarbazine/to [Drug Toxicity], procarbazine/pv [Special Situation for Pharmacovigilance], procarbazine/tm [Unexpected Outcome of Drug Treatment], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], rituximab/to [Drug Toxicity], rituximab/pv [Special Situation for Pharmacovigilance], rituximab/tm [Unexpected Outcome of Drug Treatment], vincristine/ae [Adverse Drug Reaction], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], vincristine/to [Drug Toxicity], vincristine/pv [Special Situation for Pharmacovigilance], vincristine/tm [Unexpected Outcome of Drug Treatment], complete response rate, drug fatality/si [Side Effect], adult, age, aged, article, cancer combination chemotherapy, cancer patient, cancer prognosis, cancer radiotherapy, cancer regression, cancer survival, clinical article, clinical outcome, cohort analysis, consolidation chemotherapy, controlled study, drug dose reduction, drug megadose, female, human, immunocompetence, male, median survival time, multiple cycle treatment, neurotoxicity/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27443Test
Leukemia and Lymphoma
LibKey Link

مصطلحات الفهرس: rituximab/dt [Drug Therapy], vincristine/dt [Drug Therapy], vincristine sulfate/cb [Drug Combination], vincristine sulfate/cm [Drug Comparison], vincristine sulfate/dt [Drug Therapy], bcl2 gene, BCL6 gene, gene rearrangement, Herpes simplex virus, human, lymphoma, maintenance therapy, mantle cell lymphoma/dt [Drug Therapy], multiple myeloma/th [Therapy], myeloma/th [Therapy], New Zealand, oncogene myc, pandemic, patient attitude, priority journal, salvage therapy, screening test, telehealth, vaccination, virus shedding, virus transmission, cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], doxorubicin/cb [Drug Combination], doxorubicin/cm [Drug Comparison], doxorubicin/dt [Drug Therapy], etoposide/cb [Drug Combination], etoposide/dt [Drug Therapy], growth factor, ibrutinib/dt [Drug Therapy], ifosfamide/cb [Drug Combination], ifosfamide/dt [Drug Therapy], immunoglobulin, methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], Myc protein/ec [Endogenous Compound], prednisolone/cb [Drug Combination], prednisolone/cm [Drug Comparison], prednisolone/dt [Drug Therapy], prednisone/cb [Drug Combination], prednisone/cm [Drug Comparison], prednisone/dt [Drug Therapy], protein bcl 2/ec [Endogenous Compound], protein bcl 6/ec [Endogenous Compound], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], venetoclax/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/cm [Drug Comparison], AL amyloidosis, antifungal therapy, article, Australian, autologous stem cell transplantation, B cell lymphoma/dt [Drug Therapy], Burkitt lymphoma/dt [Drug Therapy], cancer grading, cancer immunotherapy, cancer radiotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], coronavirus disease 2019, diagnostic test, diffuse large B cell lymphoma/rt [Radiotherapy], follicular lymphoma/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29271Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: clinical trial (topic), diffuse large B cell lymphoma/dt [Drug Therapy], diffuse large B cell lymphoma/rt [Radiotherapy], drug efficacy, follow up, functional status, geriatric patient, histopathology, human, International Prognostic Index, letter, clinical outcome, overall survival, patient safety, positron emission tomography, priority journal, progression free survival, proportional hazards model, rare disease, risk factor, salvage therapy, treatment duration, multiple cycle treatment, B cell lymphoma, cancer prognosis, cancer radiotherapy, cancer recurrence, cancer staging, cancer survival, cancer therapy, chemoradiotherapy, advanced cancer/dt [Drug Therapy], treatment response, cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], ibritumomab tiuxetan/dt [Drug Therapy], lactate dehydrogenase/ec [Endogenous Compound], rituximab/dt [Drug Therapy], rituximab/tm [Unexpected Outcome of Drug Treatment], Eastern Cooperative Oncology Group Performance Status, age, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28932Test
Journal of Clinical Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: rituximab/dt [Drug Therapy], vincristine/dt [Drug Therapy], vincristine sulfate/cb [Drug Combination], vincristine sulfate/cm [Drug Comparison], vincristine sulfate/dt [Drug Therapy], bcl2 gene, BCL6 gene, gene rearrangement, Herpes simplex virus, human, lymphoma, maintenance therapy, mantle cell lymphoma/dt [Drug Therapy], multiple myeloma/th [Therapy], myeloma/th [Therapy], New Zealand, oncogene myc, pandemic, patient attitude, priority journal, salvage therapy, screening test, telehealth, vaccination, virus shedding, virus transmission, cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], doxorubicin/cb [Drug Combination], doxorubicin/cm [Drug Comparison], doxorubicin/dt [Drug Therapy], etoposide/cb [Drug Combination], etoposide/dt [Drug Therapy], growth factor, ibrutinib/dt [Drug Therapy], ifosfamide/cb [Drug Combination], ifosfamide/dt [Drug Therapy], immunoglobulin, methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], Myc protein/ec [Endogenous Compound], prednisolone/cb [Drug Combination], prednisolone/cm [Drug Comparison], prednisolone/dt [Drug Therapy], prednisone/cb [Drug Combination], prednisone/cm [Drug Comparison], prednisone/dt [Drug Therapy], protein bcl 2/ec [Endogenous Compound], protein bcl 6/ec [Endogenous Compound], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], venetoclax/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/cm [Drug Comparison], AL amyloidosis, antifungal therapy, article, Australian, autologous stem cell transplantation, B cell lymphoma/dt [Drug Therapy], Burkitt lymphoma/dt [Drug Therapy], cancer grading, cancer immunotherapy, cancer radiotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], coronavirus disease 2019, diagnostic test, diffuse large B cell lymphoma/rt [Radiotherapy], follicular lymphoma/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29271Test
Internal Medicine Journal
LibKey Link